Plasma KIM-1 levels may be a useful, noninvasive biomarker for risk prognostication in metastatic RCC. Circulating kidney injury molecule-1 (KIM-1) predicts survival outcomes in patients with ...

There were a number of notable developments for patients with kidney cancer at the symposium, Dr. Emre Yekedüz explained.

The Organ-on-a-Chip (OOAC) technology simulates various organ systems depending on the specific cell types seeded onto the ...

A research team at Korea University's Vaccine Innovation Center (Center Director Jung Hee-jin) announced promising results in research on mRNA vaccine development to prevent hantavirus infections.In a ...

A terminally Southampton ill man has told of his upset as his son has been barred from travelling with him in an ambulance ...

Prior studies have shown that high circulating KIM-1 is a biomarker for: 10-13 Early detection and risk stratification of RCC Higher risk of recurrence after nephrectomy (ASSURE, CM 914, IMmotion010) ...

Results: Initial administration of apelin-13 did not improve tubular injury, creatinine clearance, or plasma urea level after renal I/R. Moreover, KIM-1 and NGAL markers were markedly increased after ...

After her recent health scare and multiple hospitalisation, South African singer and songwriter Holly Rey took to social ...

WASHINGTON – Industry stakeholders are carefully weighing their response to CMS’s proposed decision on coverage for ...

Promising tools in this field include Kidney Injury Molecule-1 (KIM-1) and ctDNA: Dr. Albiges concluded as follows: Adjuvant therapy for eligible RCC patients post-nephrectomy is standard of care!

During a live event, Benjamin Garmezy, MD, discussed treatment options in renal cell carcinoma including IO/TKI combinations ...

The 94-year-old investor has seen more cycles than almost anyone alive. His moves are rarely impulsive and often signal ...